Expression Table for this CRE
| CNhs13093 | mesenchymal precursor cell - ovarian cancer metastasis, donor2 | 23.6 |
| CNhs13076 | Smooth Muscle Cells - Umbilical Vein, donor3 | 18.0 |
| CNhs13092 | mesenchymal precursor cell - ovarian cancer left ovary, donor2 | 13.8 |
| CNhs13080 | Renal Glomerular Endothelial Cells, donor4 | 12.7 |
| CNhs14080 | locus coeruleus, newborn, donor10223 | 7.0 |
| SRX6586362 | CNhi10331_MCF-7_siRNA (HSS179267) treatment-48h_rep2 | 6.2 |
| SRX6586360 | CNhi10331_MCF-7_siRNA (HSS104864) treatment-48h_rep3 | 4.7 |
| SRX6586357 | CNhi10330_MCF-7_siRNA-negative control-48h_rep5 | 4.4 |
| CNhs12565 | MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1 | 4.3 |
| SRX6586338 | CNhi10317_MCF-7_Rosuvastatin-30 uM-6h_rep3 | 4.1 |
| SRX6586352 | CNhi10330_MCF-7_siRNA (HSS104864) treatment-48h_rep1 | 4.0 |
| CNhs13469 | CD14+ monocytes - treated with Group A streptococci, donor1 | 4.0 |
| SRX6586361 | CNhi10331_MCF-7_siRNA (HSS179267) treatment-48h_rep1 | 3.9 |
| SRX6586348 | CNhi10319_MCF-7_Fluvastatin-30 uM-48h_rep3 | 3.8 |
| SRX6586341 | CNhi10318_MCF-7_Atrovastatin-30 uM-48h_rep3 | 3.7 |
| CNhs12844 | vein, adult | 3.7 |
| SRX6586337 | CNhi10317_MCF-7_Rosuvastatin-30 uM-6h_rep2 | 3.5 |
| SRX6586353 | CNhi10330_MCF-7_siRNA-negative control-48h_rep1 | 3.4 |
| CNhs12815 | Monocyte-derived macrophages repsonse to LPS, 22hr, donor1 (t23 Subject1) | 3.3 |
| CNhs13379 | Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2) | 3.2 |
| CNhs12850 | penis, adult | 3.1 |
| SRX6586342 | CNhi10318_MCF-7_Non-treatment (DMSO)-48h_rep6 | 3.0 |
| SRX6586347 | CNhi10319_MCF-7_Fluvastatin-30 uM-48h_rep2 | 2.9 |
| SRX6586339 | CNhi10318_MCF-7_Atrovastatin-30 uM-48h_rep1 | 2.9 |
| CNhs14429 | COBL-a rinderpest infection, 24hr, biol_rep2 | 2.8 |
| SRX4504708 | human CAGE MCF-7, response to HRG, 30 min, biol_rep1 | 2.8 |
| CNhs14601 | Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2 | 2.8 |
| CNhs14436 | COBL-a rinderpest(-C) infection, 06hr, biol_rep2 | 2.7 |
| CNhs12872 | Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12) | 2.5 |
| CNhs11375 | Endothelial Cells - Aortic, donor2 | 2.4 |
| SRX9760372 | skeletal muscle_3_h_after_exercise (Individual 8) | 2.4 |
| SRX9760381 | skeletal muscle_1_h_after_exercise (Individual 10) | 2.4 |
| CNhs10881 | Nucleus Pulposus Cell, donor1 | 2.4 |
| CNhs10616 | bladder, adult, pool1 | 2.4 |
| CNhs13839 | iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2 | 2.4 |
| CNhs13831 | iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1 | 2.4 |
| SRX6586336 | CNhi10317_MCF-7_Rosuvastatin-30 uM-6h_rep1 | 2.3 |
| CNhs13363 | Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17) | 2.3 |
| SRX4504692 | human CAGE MCF-7, biol_rep2 | 2.3 |
| CNhs14427 | COBL-a rinderpest infection, 12hr, biol_rep3 | 2.3 |
| CNhs10618 | cervix, adult, pool1 | 2.3 |
| SRX4504714 | human CAGE MCF-7, response to HRG, 15 min, biol_rep2 | 2.3 |
| CNhs14595 | Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1 | 2.3 |
| SRX6586354 | CNhi10330_MCF-7_siRNA-negative control-48h_rep2 | 2.3 |
| CNhs12080 | Meningeal Cells, donor2 | 2.2 |
| SRX6586355 | CNhi10330_MCF-7_siRNA-negative control-48h_rep3 | 2.2 |
| CNhs13374 | Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47) | 2.2 |
| SRX6586346 | CNhi10319_MCF-7_Fluvastatin-30 uM-48h_rep1 | 2.2 |
| CNhs14598 | Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2 | 2.2 |
| SRX12709147 | Heart (Sample 31); the left and right atrial free wall, right and left ventricular base, and inferior and superior sinoatrial node | 2.2 |